GADD45G and hepatocellular carcinoma: In previous study, we have confirmed that GADD45G is an effective target of 4-methoxydalbergione (4MOD) in the anti-HCC process, and the downregulation of GADD45G can reduce the inhibitory effect of 4MOD on HCC [15].